Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
new york blog main
6
×
boston blog main
boston top stories
national top stories
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
startups
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
boston
clinical trials
deals
eli lilly
fda
lasmiditan
migraine
teva pharmaceutical
triptans
23andme
What
drugs
6
×
new
6
×
aims
ceo
developing
drug
medicines
neuro
research
adds
analyzes
approach
approval
arguments
backed
bails
based
big
bio
biotech
brand
bridgebio
called
capital
car
cause
cholesterol
class
commercialized
companies
company
competitors
data
debuts
decades
develop
devices
electronic
emerges
epigenetic
Language
unset
Current search:
new
×
drugs
×
" new york blog main "
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO